Seattle Genetics (MM)
   
To register click here

Seattle Genetics Stock Price SGEN

Company Description : A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. url: www.seattlegenetics.com

Name:
Seattle Genetics (MM)
Symbol:
NASDAQ:SGEN
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
-0.29-2.6210.794.8511.4911.2110.4811.0190814816:59:29
To register Click hereRegister for free Seattle Genetics stock prices.

CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma : - Data presented at the 2008 ASCO Annual Meeting - BRANFORD, Conn., June 1 /PRNewswire-FirstCall/ -- CuraGen Corporation (NASDAQ:CRGN) today presented encouraging results from the ongoing Phase I/II study of CR011-vcMMAE...

Free Seattle Genetics Stock Charts

Seattle Genetics Historical Stock Chart
Seattle Genetics Historical Stock Chart
Seattle Genetics Monthly Stock Chart
Seattle Genetics Monthly Stock Chart
Seattle Genetics Intraday stock chart
Seattle Genetics Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Seattle Genetics stock Price, quotes, trades and FREE Seattle Genetics stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Seattle Genetics (SGEN) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Seattle Genetics News

Latest Seattle Genetics News Headlines
DateTimeSource
Headline
06/01/20086:00PMPRNUSCuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
01/18/20087:24AMTFNFSeattle Genetics public offering of 10 million share priced at $9 a share
01/14/20087:23AMTFNFSeattle Genetics plans 10 million share public offering of stock
12/10/20078:35AMTFNFSeattle Genetics' SGN-33 shows multiple complete remissions in a Phase Ia trial
12/07/20079:36AMTFNFSeattle Genetics initiates SGN-40 phase IIb clinical trial
10/31/20079:49AMTFNFSeattle Genetics gets $1.5 million payment from MedImmune under license pact
10/24/20074:05PMPRNUSCuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma

Seattle Genetics Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Seattle Genetics company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Seattle Genetics Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  7550 10.7723 07/25/2008 4:47PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
35 site:2us nasdaq sgen080725 18:16 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )